Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis
Summary
This summary is machine-generated.Reverse isolation with prophylactic antibiotics significantly reduced infections and infectious deaths in acute nonlymphocytic leukemia patients. This approach also improved remission rates and survival compared to standard ward care.
Area Of Science
- Hematology
- Infectious Disease Prevention
- Oncology
Background
- Patients with acute nonlymphocytic leukemia undergoing remission induction are highly susceptible to infections.
- Prophylactic measures are crucial to reduce infection-related morbidity and mortality in these immunocompromised patients.
Purpose Of The Study
- To evaluate the efficacy of reverse isolation and prophylactic oral nonabsorbable antibiotics in preventing infections among adults with acute nonlymphocytic leukemia.
- To compare the outcomes of laminar air flow room reverse isolation with antibiotics (LAF plus A), routine ward care with antibiotics (W plus A), and ward care alone (W).
Main Methods
- A randomized study involving 64 noninfected adults with acute nonlymphocytic leukemia.
- Patients were allocated to three groups: LAF plus A, W plus A, or W.
- Infections, bacteremias, and clinical outcomes were monitored.
Main Results
- The LAF plus A group demonstrated a significant reduction in total infections, bacteremias, pneumonias, rectal abscesses, urinary tract infections, and pharyngitis.
- Infectious deaths were reduced, and the time to first or fatal infection was delayed in the LAF plus A group.
- Ward patients regularly taking antibiotics (W plus A) showed similar infection reduction, while those intolerant had comparable infection rates to the ward-only group. Both LAF plus A and W plus A groups achieved higher complete remission rates and longer median survival.
Conclusions
- Reverse isolation combined with prophylactic oral nonabsorbable antibiotics is effective in reducing infections and improving outcomes in acute nonlymphocytic leukemia patients.
- Prophylactic antibiotics, when tolerated, can mitigate infection risk even in standard ward settings.
- These protective strategies enhance remission rates and prolong survival in leukemia patients.
View abstract on PubMed